Published Mar 26, 2019

Abcuro announces pre-clinical data on new immuno-oncology target

Member News

Related or similar articles

December 9, 2021

Bulfinch Leases 40,000 Square Feet to Labshares

BOSTON & NEWTON, Mass.--(BUSINESS WIRE)--The Bulfinch Companies, Inc. (Bulfinch), a commercial real estate and investment firm, and Labshares Newton today announced the expansion of the life science and biotech co-working incubator at Chapel Bridge..
Labshares News
January 3, 2025

Exciting Equipment Additions to Labshares: Innovating Your Research

Labshares News
May 12, 2025

Leasing / Subleasing vs. Shared Labs: Why Labshares is the Capital-Efficient Choice for Biotechs

Blog Posts